New hope against drug-resistant lung bacteria? rifabutin trial begins

This study tests whether the antibiotic rifabutin can improve treatment for people with a stubborn lung infection caused by Mycobacterium abscessus that has become resistant to the common antibiotic clarithromycin. Researchers will enroll 60 adults with active lung disease and measure how well rifabutin works. The goal is to find a better way to control this difficult-to-treat infection.